期刊論文| 1. | Seeman P、Tallerico T(1998)。Antipsychotic drugs which illicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors。Mol Psychiatry，3，123-134。   |
| 2. | Jones PB、Barnes TR、Davies L(2006)。Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study。Arch Gen Psychiatry，63，1079-1087。 |
| 3. | Miller DD、Caroff SN、Davis SM(2008)。Extrapyramidal side-effects of antipsychotics in a randomised trial。Br J Psychiatry，193，279-288。 |
| 4. | Peluso MJ、Lewis SW、Barnes TR(2012)。Extrapyramidal motor side-effects of fi rst-and second- generation antipsychotic drugs。Br J Psychiatry，200，387-392。 |
| 5. | Moore TA、Buchanan RW、Buckley PF(2007)。The Texas Medication Algorithm Project: antipsychotic algorithm for schizophrenia: 2006 update。J Clin Psychiatry，68，1751-1762。 |
| 6. | Ganguly R、Kotzan JA、Miller LS(2004)。Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000。J Clin Psychiatry，65，1377-1388。 |
| 7. | Gilmer TP、Dolder CR、Folsom DP(2007)。Antipsychotic polypharmacy trends among Medicaid benefi ciaries with schizophrenia in San Diego County, 1999-2004。Psychiatr Serv，58，1007-1010。 |
| 8. | Mojtabai R、Olfson M(2010)。National trends in psychotropic medication polypharmacy in office-based psychiatry。Arch Gen Psychiatry，67，26-36。 |
| 9. | Dolder CR、McKinsey J(2011)。Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit。J Psychiatr Pract，17，368-374。 |
| 10. | Lerma-Carrillo I、de Pablo Bruhlmann S、del Pozo ML(2008)。Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit。Clin Neuropharmacol，31，319-332。 |
| 11. | Schneider LS、Tariot PN、Dagerman KS(2006)。Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease。N Engl J Med，355，1525-1538。 |
| 12. | De Hert M、Wampers M、van Winkel R(2007)。Anticholinergic use in hospitalized schizophrenic patients in Belgium。Psychiatry Res，152，165-172。 |
| 13. | Yang SY、Kao Yang YH、Chong MY(2007)。Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study。Clin Pharmaco Ther，81，586-594。 |
| 14. | Pandurangi AK、Dalkilic A(2008)。Polypharmacy with second- generation antipsychotics: a review of evidence。J Psychiatr Pract，14，345-367。 |
| 15. | Sernyak MJ、Rosenheck R(2004)。Clinicians' reasons for antipsychotic coprescribing。J Clin Psychiatry，65，1597-1600。 |
| 16. | Taylor D(2000)。Low dose typical antipsychotics: a brief evaluation。Psychiatr Bull，24，465-468。 |
| 17. | 王仁邦(20130600)。Excessive Use of Sedatives/Hypnotics/Anxiolytics in Taiwan。臺灣精神醫學，27(2)，95-98。 |
| 18. | Tor PC、Ng TP、Yong KH(2011)。Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008。Int J Neuropsychopharmacol，14，735-745。 |
| 19. | Leucht S、Barnes TRE、Kissling W(2003)。Relapse prevention in schizophrenia with new generation antipsychotics: a systematic review and exploratory meta-analysis of randomized controlled trials。Am J Psychiatry，160，1209-1214。 |
| 20. | Miller R(1997)。Dose-response relationships for the antipsychotic effects and parkinsonian side-effects of typical neuroleptic drugs: practical and theoretical implications。Prog Neuropsychopharmacol Biol Psychiatry，21，1059-1094。 |
| 21. | Procyshyn RM、Kennedy NB、Tse G(2001)。Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution。Can J Psychiatry，46，334-339。 |
| 22. | Tauscher J、Hussain T、Agid O(2004)。Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics。Am J Psychiatry，161，1620-1625。 |
| 23. | Tandon R、Jibson MD(2003)。Efficacy of newer generation antipsychotics in the treatment of schizophrenia。Psychoneuroendocrinology，28，9-26。 |
| 24. | Lieberman, Jeffrey A.(2004)。Dopamine Partial Agonists: A New Class of Antipsychotic。CNS Drugs，18(4)，251-267。 |
| 25. | Xiang, Y. T.、Wang, C. Y.、Si, T. M. et al.(2012)。Antipsychotic Polypharmacy in Inpatients with Schizophrenia in Asia (2001-2009)。Pharmacopsychiatry，45，7-12。 |
| 26. | 林喬祥、蕭正誠、黃玉書、呂少鈞、盧孟良、臧汝芬、魯思翁、West, Teena Maree、沈武典(20100600)。Patient Characteristics and Treatment Discontinuation in a Taiwanese Cohort of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study。Taiwanese Journal of Psychiatry，24(2)，110-121+162。 延伸查詢 |
| 27. | Lieberman, J. A.、Stroup, T. S.、McEvoy, J. P.、Swartz, M. S.、Rosenheck, R. A.、Perkins, D. O.、Hsiao, J. K.(2005)。Effectiveness of antipsychotic drugs in patients with chronic schizophrenia。New England Journal of Medicine，353(12)，1209-1223。 |
| 28. | Freemantle, Nick、Geddes, John、Bebbington, Paul、Harrison, Paul(2000)。Atypical Antipsychotics in the Treatment of Schizophrenia: Systematic Overview and Meta-regression Analysis。British Medical Journal，321(7273)，1371-1376。 |
| 29. | Glich, Ira D.、陳小紅、Davis, John M.(2003)。A Meta-analysis of the Efficacy of Second-generation Antipsychotics。Archives of General Psychiatry，60(6)，553-564。 |
| 30. | Huang, SS、Liao, YC、Hsieh, YY(2006)。Combination antipsychotic therapy in psychiatric outpatient clinics in Taiwan。Compr Psychiatry，47，421-425。 |
| 31. | Rummel-Kluge, C.、Komossa, K.、Schwarz, S.、Schmid, F.、Kissling, W.、Davis, JM.、Leucht S.(201201)。Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons。Schizophr Bull，38(1)，167-177。 |